This is a Haematology trial which enables us to offer patients with acute myeloid leukaemia who, in standard care, would require urgent intensive chemotherapy over many months as a hospital inpatient, to potentially access an intensive modified regime that they can administer themselves in their own home.
Ysbyty Gwynedd’s Haematology team has recently been awarded the Myeloma UK Clinical Service Excellence Programme Award in recognition of its outstanding care and dedication to patients with myeloma, and Ysbyty Glan Clwyd have been named runners up in the National Acute Myeloid Leukaemia Trial Team of the Year Award.